![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 26, 27302-27314, June 25, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



||
From the
Departments of
Medicine and ¶Medical Biology, Faculty of Medicine, Laval University, and
CHUL/CHUQ Medical Research Center, Québec City, Québec G1V 4G2, Canada
Thioredoxin-2 (Trx2) is a mitochondrial protein-disulfide oxidoreductase essential for control of cell survival during mammalian embryonic development. This suggests that mitochondrial thioredoxin reductase-2 (TrxR2), responsible for reducing oxidized Trx2, may also be a key player in the regulation of mitochondria-dependent apoptosis. With this in mind, we investigated the effects of overexpression of TrxR2, Trx2, or both on mammalian cell responses to various apoptotic inducers. Stable transfectants of mouse Neuro2A cells were generated that overexpressed TrxR2 or an EGFP-TrxR2 fusion protein. EGFP-TrxR2 was enzymatically active and was localized in mitochondria. TrxR2 protein level and TrxR activity could be increased up to 6-fold in mitochondria. TrxR2 and EGFP-TrxR2 transfectants showed reduced growth rates as compared with control cells. This growth alteration was not due to cytotoxic effects nor related to changes in basal mitochondrial transmembrane potential (
m), reactive oxygen species production, or to other mitochondrial antioxidant components such as Trx2, peroxyredoxin-3, MnSOD, GPx1, and glutathione whose levels were not affected by increased TrxR2 activity. In response to various apoptotic inducers, the extent of 
m dissipation, reactive oxygen species induction, caspase activation, and loss of viability were remarkably similar in TrxR2 and control transfectants. Excess TrxR2 did not prevent trichostatin A-mediated neuronal differentiation of Neuro2A cells nor did it protect them against
-amyloid neurotoxicity. Neither massive glutathione depletion nor co-transfection of Trx2 and TrxR2 in Neuro2A (mouse), COS-7 (monkey), or HeLa (human) cells revealed any differential cellular resistance to prooxidant or non-oxidant apoptotic stimuli. Our results suggest that neither Trx2 nor TrxR2 gain of function modified the redox regulation of mitochondria-dependent apoptosis in these mammalian cells.
Received for publication, March 4, 2004
* This work was supported by National Institutes of Health Grant RO1NS37718 and Subcontract NMRI98001 with the Natural Medicines Research Institute (to M. R. V. M. and M.-E. M.), and by the National Cancer Institute of Canada through Canadian Cancer Society Grants 2796 and 3488 (to M.-E. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|| To whom correspondence should be addressed: Dept. of Medicine, Entre Hospitalier de Laval University, 2705 Blvd. Laurier, Québec G1V 4G2, Canada. Tel.: 418-656-4141 (ext. 47097); Fax: 418-654-2159; E-mail: memirault{at}crchul.ulaval.ca.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
B. Bogunovic, M. Stojakovic, L. Chen, and M. Maric An Unexpected Functional Link between Lysosomal Thiol Reductase and Mitochondrial Manganese Superoxide Dismutase J. Biol. Chem., April 4, 2008; 283(14): 8855 - 8862. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Negroni, M. Samson, J.-M. Guigonis, B. Rossi, V. Pierrefite-Carle, and C. Baudoin Treatment of colon cancer cells using the cytosine deaminase/5-fluorocytosine suicide system induces apoptosis, modulation of the proteome, and Hsp90{beta} phosphorylation Mol. Cancer Ther., October 1, 2007; 6(10): 2747 - 2756. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Baker, T. Landowski, R. Dorr, W. R. Tate, J. M.C. Gard, B. E. Tavenner, T. Dragovich, A. Coon, and G. Powis The Antitumor Agent Imexon Activates Antioxidant Gene Expression: Evidence for an Oxidative Stress Response Clin. Cancer Res., June 1, 2007; 13(11): 3388 - 3394. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Patenaude, R. G. Deschesnes, J. L.C. Rousseau, E. Petitclerc, J. Lacroix, M.-F. Cote, and R. C.-Gaudreault New Soft Alkylating Agents with Enhanced Cytotoxicity against Cancer Cells Resistant to Chemotherapeutics and Hypoxia Cancer Res., March 1, 2007; 67(5): 2306 - 2316. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liang and J. L. Pietrusz Thiol-Related Genes in Diabetic Complications: A Novel Protective Role for Endogenous Thioredoxin 2 Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 77 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rohrbach, S. Gruenler, M. Teschner, and J. Holtz The thioredoxin system in aging muscle: key role of mitochondrial thioredoxin reductase in the protective effects of caloric restriction? Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R927 - R935. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tao, X. Jiao, E. Gao, W. B. Lau, Y. Yuan, B. Lopez, T. Christopher, S. P. RamachandraRao, W. Williams, G. Southan, et al. Nitrative Inactivation of Thioredoxin-1 and Its Role in Postischemic Myocardial Apoptosis Circulation, September 26, 2006; 114(13): 1395 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Biterova, A. A. Turanov, V. N. Gladyshev, and J. J. Barycki Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism PNAS, October 18, 2005; 102(42): 15018 - 15023. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nalvarte, A. E. Damdimopoulos, C. Nystom, T. Nordman, A. Miranda-Vizuete, J. M. Olsson, L. Eriksson, M. Bjornstedt, E. S. J. Arner, and G. Spyrou Overexpression of Enzymatically Active Human Cytosolic and Mitochondrial Thioredoxin Reductase in HEK-293 Cells: EFFECT ON CELL GROWTH AND DIFFERENTIATION J. Biol. Chem., December 24, 2004; 279(52): 54510 - 54517. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |